Stockreport

Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation

Cerecor, Inc  (CERC) 
Last cerecor, inc earnings: 11/14 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.cerecor.com
PDF BALTIMORE, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization [Read more]